Literature DB >> 28806280

Integrated Analysis of Biopsies from Inflammatory Bowel Disease Patients Identifies SAA1 as a Link Between Mucosal Microbes with TH17 and TH22 Cells.

Mei San Tang1, Rowann Bowcutt, Jacqueline M Leung, Martin J Wolff, Uma M Gundra, David Hudesman, Lisa B Malter, Michael A Poles, Lea Ann Chen, Zhiheng Pei, Antonio G Neto, Wasif M Abidi, Thomas Ullman, Lloyd Mayer, Richard A Bonneau, Ilseung Cho, Pʼng Loke.   

Abstract

BACKGROUND: Inflammatory bowel diseases (IBD) are believed to be driven by dysregulated interactions between the host and the gut microbiota. Our goal is to characterize and infer relationships between mucosal T cells, the host tissue environment, and microbial communities in patients with IBD who will serve as basis for mechanistic studies on human IBD.
METHODS: We characterized mucosal CD4 T cells using flow cytometry, along with matching mucosal global gene expression and microbial communities data from 35 pinch biopsy samples from patients with IBD. We analyzed these data sets using an integrated framework to identify predictors of inflammatory states and then reproduced some of the putative relationships formed among these predictors by analyzing data from the pediatric RISK cohort.
RESULTS: We identified 26 predictors from our combined data set that were effective in distinguishing between regions of the intestine undergoing active inflammation and regions that were normal. Network analysis on these 26 predictors revealed SAA1 as the most connected node linking the abundance of the genus Bacteroides with the production of IL17 and IL22 by CD4 T cells. These SAA1-linked microbial and transcriptome interactions were further reproduced with data from the pediatric IBD RISK cohort.
CONCLUSIONS: This study identifies expression of SAA1 as an important link between mucosal T cells, microbial communities, and their tissue environment in patients with IBD. A combination of T cell effector function data, gene expression and microbial profiling can distinguish between intestinal inflammatory states in IBD regardless of disease types.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28806280      PMCID: PMC5613756          DOI: 10.1097/MIB.0000000000001208

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  47 in total

1.  Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn's disease: A European multicenter trial.

Authors:  G D'haens; S Van Deventer; R Van Hogezand; D Chalmers; C Kothe; F Baert; T Braakman; T Schaible; K Geboes; P Rutgeerts
Journal:  Gastroenterology       Date:  1999-05       Impact factor: 22.682

2.  Inferred metagenomic comparison of mucosal and fecal microbiota from individuals undergoing routine screening colonoscopy reveals similar differences observed during active inflammation.

Authors:  Mei San Tang; Jordan Poles; Jacqueline M Leung; Martin J Wolff; Michael Davenport; Soo Ching Lee; Yvonne Al Lim; Kek Heng Chua; P'ng Loke; Ilseung Cho
Journal:  Gut Microbes       Date:  2015-01-20

3.  Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease.

Authors:  Floris Imhann; Arnau Vich Vila; Marc Jan Bonder; Jingyuan Fu; Dirk Gevers; Marijn C Visschedijk; Lieke M Spekhorst; Rudi Alberts; Lude Franke; Hendrik M van Dullemen; Rinze W F Ter Steege; Curtis Huttenhower; Gerard Dijkstra; Ramnik J Xavier; Eleonora A M Festen; Cisca Wijmenga; Alexandra Zhernakova; Rinse K Weersma
Journal:  Gut       Date:  2016-10-08       Impact factor: 23.059

4.  Pediatric Crohn disease patients exhibit specific ileal transcriptome and microbiome signature.

Authors:  Yael Haberman; Timothy L Tickle; Phillip J Dexheimer; Mi-Ok Kim; Dora Tang; Rebekah Karns; Robert N Baldassano; Joshua D Noe; Joel Rosh; James Markowitz; Melvin B Heyman; Anne M Griffiths; Wallace V Crandall; David R Mack; Susan S Baker; Curtis Huttenhower; David J Keljo; Jeffrey S Hyams; Subra Kugathasan; Thomas D Walters; Bruce Aronow; Ramnik J Xavier; Dirk Gevers; Lee A Denson
Journal:  J Clin Invest       Date:  2014-07-08       Impact factor: 14.808

5.  TH17, TH22 and Treg cells are enriched in the healthy human cecum.

Authors:  Martin J Wolff; Jacqueline M Leung; Michael Davenport; Michael A Poles; Ilseung Cho; P'ng Loke
Journal:  PLoS One       Date:  2012-07-19       Impact factor: 3.240

6.  Sparse PLS discriminant analysis: biologically relevant feature selection and graphical displays for multiclass problems.

Authors:  Kim-Anh Lê Cao; Simon Boitard; Philippe Besse
Journal:  BMC Bioinformatics       Date:  2011-06-22       Impact factor: 3.169

7.  Transcriptomic landscape of lncRNAs in inflammatory bowel disease.

Authors:  Aashiq H Mirza; Claus Hb Berthelsen; Stefan E Seemann; Xiaoyong Pan; Klaus S Frederiksen; Mogens Vilien; Jan Gorodkin; Flemming Pociot
Journal:  Genome Med       Date:  2015-05-13       Impact factor: 11.117

8.  Associations between host gene expression, the mucosal microbiome, and clinical outcome in the pelvic pouch of patients with inflammatory bowel disease.

Authors:  Xochitl C Morgan; Boyko Kabakchiev; Levi Waldron; Andrea D Tyler; Timothy L Tickle; Raquel Milgrom; Joanne M Stempak; Dirk Gevers; Ramnik J Xavier; Mark S Silverberg; Curtis Huttenhower
Journal:  Genome Biol       Date:  2015-04-08       Impact factor: 13.583

9.  Bacterial sensor Nod2 prevents inflammation of the small intestine by restricting the expansion of the commensal Bacteroides vulgatus.

Authors:  Deepshika Ramanan; Mei San Tang; Rowann Bowcutt; P'ng Loke; Ken Cadwell
Journal:  Immunity       Date:  2014-07-31       Impact factor: 31.745

10.  Uncoupling of mucosal gene regulation, mRNA splicing and adherent microbiota signatures in inflammatory bowel disease.

Authors:  Robert Häsler; Raheleh Sheibani-Tezerji; Anupam Sinha; Matthias Barann; Ateequr Rehman; Daniela Esser; Konrad Aden; Carolin Knecht; Berenice Brandt; Susanna Nikolaus; Sascha Schäuble; Christoph Kaleta; Andre Franke; Christoph Fretter; Werner Müller; Marc-Thorsten Hütt; Michael Krawczak; Stefan Schreiber; Philip Rosenstiel
Journal:  Gut       Date:  2016-09-30       Impact factor: 23.059

View more
  13 in total

Review 1.  Genomic and molecular alterations in human inflammatory bowel disease-associated colorectal cancer.

Authors:  Marie Muller; Franck Hansmannel; Djesia Arnone; Myriam Choukour; Ndeye Coumba Ndiaye; Tunay Kokten; Rémi Houlgatte; Laurent Peyrin-Biroulet
Journal:  United European Gastroenterol J       Date:  2020-04-08       Impact factor: 4.623

2.  CVID enteropathy is characterized by exceeding low mucosal IgA levels and interferon-driven inflammation possibly related to the presence of a pathobiont.

Authors:  Natalia Shulzhenko; Xiaoxi Dong; Dariia Vyshenska; Renee L Greer; Manoj Gurung; Stephany Vasquez-Perez; Ekaterina Peremyslova; Stanislav Sosnovtsev; Martha Quezado; Michael Yao; Kim Montgomery-Recht; Warren Strober; Ivan J Fuss; Andrey Morgun
Journal:  Clin Immunol       Date:  2018-09-19       Impact factor: 3.969

3.  Single-Cell Transcriptional Survey of Ileal-Anal Pouch Immune Cells From Ulcerative Colitis Patients.

Authors:  Joseph C Devlin; Jordan Axelrad; Ashley M Hine; Shannon Chang; Suparna Sarkar; Jian-Da Lin; Kelly V Ruggles; David Hudesman; Ken Cadwell; P'ng Loke
Journal:  Gastroenterology       Date:  2021-02-05       Impact factor: 22.682

4.  Transcriptional Signatures That Define Ulcerative Colitis in Remission.

Authors:  Christopher G Fenton; Hagar Taman; Jon Florholmen; Sveinung W Sørbye; Ruth H Paulssen
Journal:  Inflamm Bowel Dis       Date:  2021-01-01       Impact factor: 5.325

5.  Multi-omic modelling of inflammatory bowel disease with regularized canonical correlation analysis.

Authors:  Lluís Revilla; Aida Mayorgas; Ana M Corraliza; Maria C Masamunt; Amira Metwaly; Dirk Haller; Eva Tristán; Anna Carrasco; Maria Esteve; Julian Panés; Elena Ricart; Juan J Lozano; Azucena Salas
Journal:  PLoS One       Date:  2021-02-08       Impact factor: 3.240

6.  Serum Amyloid A Proteins Induce Pathogenic Th17 Cells and Promote Inflammatory Disease.

Authors:  June-Yong Lee; Jason A Hall; Lina Kroehling; Lin Wu; Tariq Najar; Henry H Nguyen; Woan-Yu Lin; Stephen T Yeung; Hernandez Moura Silva; Dayi Li; Ashley Hine; P'ng Loke; David Hudesman; Jerome C Martin; Ephraim Kenigsberg; Miriam Merad; Kamal M Khanna; Dan R Littman
Journal:  Cell       Date:  2019-12-19       Impact factor: 41.582

7.  Plasma proteomic analysis of autoimmune hepatitis in an improved AIH mouse model.

Authors:  Han Wang; Wei Yan; Zuohua Feng; Yuan Gao; Liu Zhang; Xinxia Feng; Dean Tian
Journal:  J Transl Med       Date:  2020-01-06       Impact factor: 5.531

8.  Enterocytes, fibroblasts and myeloid cells synergize in anti-bacterial and anti-viral pathways with IL22 as the central cytokine.

Authors:  Jean Paul Ten Klooster; Marianne Bol-Schoenmakers; Kitty van Summeren; Arno L W van Vliet; Cornelis A M de Haan; Frank J M van Kuppeveld; Saertje Verkoeijen; Raymond Pieters
Journal:  Commun Biol       Date:  2021-05-27

Review 9.  Big data in IBD: big progress for clinical practice.

Authors:  Nasim Sadat Seyed Tabib; Matthew Madgwick; Padhmanand Sudhakar; Bram Verstockt; Tamas Korcsmaros; Séverine Vermeire
Journal:  Gut       Date:  2020-02-28       Impact factor: 23.059

10.  A Distinct Innate Immune Signature of Early Onset Colorectal Cancer.

Authors:  Ivy H Gardner; Ragavan Siddharthan; Katherine Watson; Elizabeth Dewey; Rebecca Ruhl; Sokchea Khou; Xiangnan Guan; Zheng Xia; V Liana Tsikitis; Sudarshan Anand
Journal:  Immunohorizons       Date:  2021-06-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.